To investigate the pharmacodynamics of phentolamine in human corpus cavernosum (HCC) with special attention to the role of the K þ channels. Strips of HCC precontracted with nonadrenergic stimuli and kept in isometric organ bath immersed in a modified Krebs-Henseleit solution enriched with guanethidine and indomethacine were used in order to study the mechanism of the phentolamine-induced relaxation. Phentolamine caused relaxation (E50%) in HCC strips precontracted with K þ 40 mM. This effect was not blocked by tetrodotoxin (1 lM) (54.674.6 vs 48.976.4%) or (atropine (10 lM) (52.776.5 vs 58.675.6%). However, this relaxation was significantly attenuated by L-NAME (100 lM) (59.775.8 vs 27.877.1%; Po0.05; n ¼ 8) and ODQ (100 lM) (62.775.1 vs 26.873.9%; Po0.05; n ¼ 8). Charybdotoxin and apamin (K Ca -channel blockers) did not affect the phentolamine relaxations (54.674.6 vs 59.375.2%). Glibenclamide (100 lM), an inhibitor of K ATP -channel, caused a significant inhibition (56.776.3 vs 11.372.3%; Po0.05; n ¼ 8) of the phentolamine-induced relaxation. In addition, the association of glibenclamide and L-NAME almost abolished the phentolamine-mediated relaxation (54.675.6 vs 5.771.4%; Po0.05; n ¼ 8). The results suggest that phentolamine relaxes HCC by a nonadrenergicnoncholinergic mechanism dependent on nitric oxide synthase activity and activation of K ATPchannel.
Introduction
Erectile dysfunction (ED) defined as an inability to achieve and/or maintain an erection sufficient for satisfactory sexual activity, 1 is prevalent in 46.2% of the Brazilian male population. 2 In a more recent publication it is estimated that 1 025 600 new cases of ED are expected to occur in Brazil, annually. 3 Phentolamine a competitive nonselective antagonist acting on the a 1 -and a 2 -adrenoceptor with almost equal efficacy 4 has been used in combination with other vasoactive agents to treat ED, since 1984. 5 In 1998, Traish et al 6 reported studies in organ bath chamber with strips from human and rabbit corpus cavernosum, using phentolamine mesylate to examine its biochemical and physiological mechanisms of action. They concluded that the amine besides adrenergic blockade also relaxes erectile tissue by an endothelium-derived nitric oxide pathway.
Vemulapalli and Kurowski 7 demonstrated in rabbit corpus cavernous stimulated by transmural electrical field that phentolamine mesylate relaxes rabbit corpus cavernosum by activating NO synthase independent of a-adrenergic receptor blockade.
Recent evidences from several experiments with penile erectile tissues have stressed the involvement of K þ -channels in the function/regulation of erection. [8] [9] [10] At least, the calcium-sensitive (K ca ) and the ATP-regulated (K ATP ) were demonstrated to be important modulators of human muscular corporal smooth muscle tone. 11 The goal of this study was to confirm the role of phentolamine in the penile erectile NO/ c GMP pathway, and mainly to investigate the participation of the K þ channels in the mechanism of action of phentolamine-induced relaxation in human corporal tissue.
Materials and methods
All studies were performed according to a protocol approved by the ethics committee of research with human subjects of the Ceará Federal University and the National Committee of Ethics of Research of the Brazilian Health Ministry.
Human corpus cavernosum (HCC) erectile tissues were obtained from donor cadaver (n ¼ 16) during surgery for organ transplantation. A total of 64 strips (4/each donor) of human corporeal smooth muscle were excised.
After removal, the tissue was placed immediately in ice-cold transportation buffer (Collin's solution), maintained at 41C and used within 24 h after operation.
Each fragment was cut into approximately 3 Â 3 Â 8 mm 3 strips and vertically mounted in 5 ml organ chambers containing Krebs-Henseleit medium, with the following composition (mM): NaCl 114.6, KCl 4.96, MgSO 4 1.3, CaCl 2 2.0, NaH 2 PO 4 1.23, NaHCO 3 25 and 3.6 glucose and enriched with 10 mM guanethidine and 10 mM indomethacin (pH 7.4, 371C gassed with 5% CO 2 and 95% O 2 ). The experiments were carried out in baths containing guanethidine and indomethacin in order to provide an environment free of adrenergic and prostanoid influences.
Thereafter, the tissues were equilibrated for 90 min. Contractions were measured isometrically with a model FT-60 (Narco Bio-System, Houston, TX, USA) force displacement transducer and recorded on a desk model polygraph (DMP-4B, Narco Bio-Systems).
Phentolamine hydrochloride, guanethidine, indomethacin, phenylephrine, 5-hydroxytryptamine
, atropine, charybdotoxin, apamin, glibenclamide and ethyleneglycol-bis(beta-aminoethylether)-N,N 0 -tetra acetic acid (EGTA) were purchased from Sigma/Aldrich Chemical Co., and dissolved in saline the day of the esperiment. Indomethacin was diluted in bicarbonate buffer solution in order to make 1 mM stock solutions.
After an equilibration period in the bath chambers, the tissues were contracted with a highpotassium depolarizing solution (K þ 40 mM) obtained by isosmotic replacement of NaCl in the standard solution by KCl. The maximal amplitude of the phasic component of this contraction was determined for each strip before starting the experiments as an internal control and in order to test viability and reproducibility of the contractile responses. The phasic component was considered the peak deflection after 3 s exposure to the high potassium solution.
Thereafter, concentration-response curves to phentolamine (10 À9 -10 À2 M) were performed on strips tonically precontrated with either K þ (40 mM), PGF-2a (100 mM), 5-HT (10 mM) or Phenylephrine (10 mM).
The phentolamine-induced relaxation (100 mM) was compared with the effects of several relaxant agents (Acetylcholine (Ach; 1 mM), nitric oxide from sodium nitrate at pH 2 (NO; 10 mM), sodium nitroprusside (SNP; 1 mM), transmural electric field stimulation (EFS: 20 V, 0.5 ms, 20 Hz), in HCC strips tonically precontracted with K þ (40 mM). In other set of experiments, once stable tonic contraction to K þ (40 mM) was attained, phentolamine (100 mM) was added to the organ bath chambers in the absence or presence of 100 mM tetrodotoxin, 10 mM atropine, 100 mM L-NAME, 100 mM ODQ, 100 nM charybdotoxin plus 10 mM apamin, or 100 mM glibenclamide. All the pharmacological blockers were incubated in the bath chamber during 5 min before adding phentolamine. The tonic contractile component of the high potassium solution is considered the peak deflection after the phasic component has faded away.
In order to test if phentolamine would relax HCC by blocking voltage-dependent calcium channels, a study was carried out on HCC strips, comparing the pretreatment with phentolamine or nifedipine against the phasic component of the contraction induced by K þ (40 mM), that is mainly dependent on calcium influx through these channels. This hypothesis was tested after 5-min incubation with phentolamine or nifedipine.
In another set of experiments the relaxation induced by phentolamine in strips tonically precontracted with PGF-2a was assayed in normal Krebs-Henseleit solution with 2 mM calcium and then compared with the relaxation obtained when the tissues were contracted by the same agonist but in a medium with zero nominal calcium ('Ca 2 þ -free' solution), in the presence of EGTA (100 mM).
The relaxation data were normalized as a percent of the tonic component of the contraction elicited by K þ (40 mM) for each preparation and expressed as mean7s.e.m., and compared with the response obtained by isovolumetric addition of vehicle. Each protocol was made separated.
The statistical differences among doses and in relation to control were analyzed by the variance test one-way ANOVA with Tukey test as post hoc, with 5% significance.
Differences among the relaxation obtained before and after the specific blockers were compared by paired two-tailed Student t-test with significance level set at 5%.
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Results
In a first series of experiments, phentolamine elicited dose-dependent relaxations in HCC strips precontracted with several agonists (Figure 1) . The relaxation to phentolamine (100 mM) was compared with the actions of several other relaxant agents in HCC strips precontracted with K þ (40 mM), and it was observed that this component corresponds to E50% of the relaxation induced by acetylcholine (1 mM) and sodium nitroprusside (1 mM) (Figure 2) .
The phentolamine (100 mM)-induced relaxation in HCC precontracted with K þ (40 mM) was not blocked by tetrodotoxin (100 mM) or 10 mM atropine (54.674.6 vs 48.9 Â 6.4%) and (52.776.5 vs 58.675.6%) (P40.05; n ¼ 6) ( Figure 3 ). To investigate if phentolamine induces relaxation on HCC via activation of the NO/ s GC/ c GMP pathway, experiments were performed in the presence of L-NAME (100 mM) (NO synthase inhibitor) (59.775.8 vs 27.877.1%) (Po0.001; n ¼ 8) and ODQ (100 mM), a potent inhibitor of the soluble guanylyl cyclase (62.775.1 vs 26.873.9%) (Po0.05; n ¼ 8) (Figure 4) .
In order to analyze if phentolamine has any role in the L-type calcium function, the 40 mM K þ -induced contraction was compared in HCC strips pretreated with phentolamine or nifedipine, a specific inhibitor of this channel. While nifedipine effectively blocked the K þ -induced contraction, phentolamine was ineffective (0.6470.0 vs 95.870.5%) (Po0.001; n ¼ 4) (Figure 5a ). Figure 3 Effect of Phentolamine (Phento) (100 mM) in human corpus cavernosum strips precontracted with 40 mM K þ in the absence or presence of tetrodotoxin (TTX) (100 mM) or atropine (ATR) (10 mM). Po0.05, (n ¼ 6), unpaired Student t-test (treated vs control).
Phento
Phento+L-NAME Phento+ODQ Effect of Phentolamine (Phento) (100 mM) in human corpus cavernosum strips precontracted with 40 mM KCl in the absence or presence of L-NAME (100 mM) or ODQ (100 mM).
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We also tested the effects of 100 mM phentolamine in strips precontracted with 100 mM PGF-2a , in a Ca 2 þ -free medium. The phentolamine-induced relaxation was attenuated in 74.376.2 (43.676.2 vs 11.272.3) (Figure 5b ), and this blockade was reversed by washout and performing the phentolamine relaxation assay in normal Krebs-Henseleit solution (43.676.2 vs 34.874.3) (Figure 5b) .
On the other hand, pretreatment of tissues with apamin (1 mM) plus charybdotoxin (100 nM), potent inhibitors of K Ca -channel (small and large conductance, respectively) did not change the relaxation elicited by phentolamine in HCC strips precontracted with K þ 40 mM (54.674.6 Â 59.375.2%) (P40.05) (Figure 6a) .
To examine the role of K ATP -channels on the phentolamine-induced relaxation, tissues were pretreated with 100 mM glibenclamide, an ATP sensitive K þ channel blocker. Additionally a blockade was made with the pretreatment with 100 mM L-NAME plus 100 mM glibenclamide. An inhibition (80.172.3) in the phentolamine-induced relaxation was shown (56.776.3 vs 11.372.3%; Po0.05) or phentolamine þ glibenclamide þ L-NAME (54.675.6 vs 5.771.4%) (Po0.05) (Figure 6b ).
Discussion
Phentolamine mesylate has been used since 1984 with other vasoactive drugs, by intracavernous injection, for the treatment of ED. Later, the observations of Gwinup 12 formed the basis for the use of an oral formulation of phentolamine to treat ED. 6, 13 Phentolamine mesylate is an effective a 1 and a 2 adrenergic blocker both in human and rabbit corpus cavernosum. 6 Some studies have shown the relative efficacy of this formulation for long-term preventive pharmacological treatment of ED for men with mild to moderate ED. [14] [15] [16] One study has shown no difference in the success rate of sexual intercourse of patients treated with phentolamine or sildenafil. 17 The inhibition of the physiologic sympathetic tonus by phentolamine leads to relaxation of the HCC. 6 Nevertheless, this does not seem to be the only mechanism of the relaxation induced by phentolamine, at least in in vitro conditions. Traish et al 6 and Vemulapalli and Kurowski 
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This relaxation corresponds, in the higher concentration used (100 mM), to E50% of the relaxations induced by classical agonists, as acetylcholine (1 mM), nitric oxide (10 mM), transmural electrical field stimulation, or sodium nitroprusside (1 mM), and is time-dependent with maximal response attained 30 min after incubation. The participation of relaxant prostanoids in this effect is unlikely, since all the experiments were carried out under indomethacin blockade of the cyclooxygenase enzymes.
The nonadrenergic relaxation induced by phentolamine is not neurogenic in nature, since it is not sensitive to tetrodotoxin and is also not dependent on direct activation of muscarinic receptors, being atropine-insensitive.
This nonadrenergic component is not fully understood so far. Traish et al 6 and Vemulapalli and Krouski 7 working with rabbit corpora cavernosa showed that this component is partially dependent on endothelial and neuronal nitric oxide synthase activity. Nevertheless, Palea and Barras 18 also working with rabbit corpus cavernosum, showed that this component is insensitive to 100 mM L-NAME and concluded that the relaxation induced by phentolamine is independent of nitric oxide.
The nonadrenergic component of the phentolamine-induced relaxation was shown, in the present study carried out with HCC, to be both dependent in the activity of nitric oxide synthase and soluble guanylyl cyclase, since it was partially inhibited by L-NAME and ODQ (Figure 4 ). This reinforces the data presented by Traish and Vemulapalli pointing to a NO/GMPc based mechanism. The contrast with the data presented by Palea and Barras is probably due to dose and specie differences. For instance, Palea used 10 mM phentolamine and we used a 10-fold higher dose.
Nevertheless, this partial blockade by L-NAME or ODQ does not fully explain the phenomenon. Another mechanism underlying phentolamineinduced relaxation was supposed to exist.
A calcium-channel blockade by phentolamine was discarded since this compound at the higher dose used, that is, 100 mM, did not inhibit the highpotassium induced contraction. This phasic contraction is highly dependent on calcium influx by voltage-dependent calcium channels 19 and, in our experiments, was fully blocked by nifedipine (Figure 5a ).
The addition of phentolamine to HCC precontracted with PGF-2a in a 'Ca 2 þ -free' medium revealed that this drug does not act downstream in the calcium-signaling pathway, as in its release from internal stores, interaction with calmodulin, or any event in the action of calcium as a second messenger. Furthermore, it is unlikely that phentolamine would interact directly with the contractile machinery. The reversibility of this effect in a normal Krebs-Henseleit solution shows that phentolamine does not induce damage to the contractile machinery.
Otherwise, potassium channels are physiological regulators of the membrane electric potential and transmembrane calcium flux, thus they have a key role in the regulation of smooth muscle tone including HCC. 20 Two isoforms of the channel, that is, the calcium-activated channels (K ca ) and adenosine triphosphate-sensitive channel (K ATP ), are the main modulators of the tone of the erectile tissue.
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At least, injections of the K ATP -channel openers cromakalim and pinacidil in rabbit corpus cavernosum leads to relaxation, 8 intracavernosal injections of pinacidil, nicorandil, and lemakalim induces erection in cats, monkeys, and humans. 9, [21] [22] [23] [24] [25] The blockade of K ca -channels (both high Maxi-K and low-conductance K ca ), by charybdotoxin and apamin, respectively, did not affect the phentolamine-induced relaxation and therefore K ca -channels are not likely to be involved in this phenomenon (Figure 6a) .
Nevertheless, the phentolamine-induced relaxation was highly (E90%) inhibited by glibenclamide, pointing to a K ATP -channel role in this effect. In addition, the combination of glibenclamide and L-NAME were not additive showing that the NO/ GC/ c GMP pathway is probably linked to the activation of the K ATP -channel, as demonstrated by Lin et al (Figure 6b ). 26 The role of K ATP channels in the relaxation of the HCC are being studied and point to a role of K ATP openers as second line alternatives in the management of drug refractory ED. 11, 27 The chemical management of phentolamine, as a mother drug, would lead to compounds that could increment NO stimulating and K ATP opening activity keeping the a-adrenergic blocker property.
Whatever the case, the present study reports for the first time that the nonadrenergic component of the relaxation induced by phentolamine in the HCC is highly dependent on K ATP channel opening mechanism.
